DRUG · Unmapped registry intervention
LY900014
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy
NCT02703350
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Insulin Lispro
Normalized identity: insulin lisproView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetes Mellitus, Type 1unresolved
Interventions
LY900014DRUG
Insulin LisproDRUG · verified · RxNorm: insulin lispro
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02703350 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.